Medicinal use of cannabis in the treatment of pain in Spain.
Interview conducted by the Spatial Interest Group on Pain (GIED), dissemination body of the Argentine Association for the Study of Pain (AAED)
DOI:
https://doi.org/10.47924/neurotarget2018131Keywords:
pain, Medicinal use of cannabisAbstract
We interviewed Dr. Carlos Goicoechea García, Professor of Pharmacology and Director of Basic Health Sciences from the Rey Juan Carlos University of the Alcorcón Campus, Madrid, Spain and Coordinator of the Multidisciplinary Research and Treatment of Pain group “I+Dol” URHC-Santander Universities.
Metrics
References
Kim PS, Fishman MA. Canabis for Pain and Headaches: PrimerCurr. Pain Headache Rep. 2017, 21(4):19.
Corroon JM Jr, Mischley LK, Sexton M. Canabis asa substitute for prescription drugs – a cross-sectional study. J Pain Res. 2017, 10:989-998.
Fanelli G, De Carolis G, Leonardi C, Longobardi A,Sarli E, Allegri M, Schatman ME. Canabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients. Journal of Pain Research 2017; 10:1217–1224.
Martín Fontelles MI, Goicoechea García C. Role ofcannabinoids in the management of neuropathic pain. CNS Drugs. 2008, 22(8):645-53.
Ware MA. Canabis and cancer: toward a new understanding. Curr Oncol. 2016, 23(2):S5-6.
Aggarwal SK. Use of cannabinoids in cancer care: palliative care. Curr Oncol. 2016, 23(2):S33-6.
Velasco G, Sánchez C, Guzmán M. Anticancer mechanisms of cannabinoids. Curr Oncol. 2016, 23(2):S23-32.
Abrams DI. Integrating canabis into clinical cancer care.Curr Oncol. 2016, 23(2):S8-S14.
Solimini R, Rotolo MC, Pichini S, Pacifici R. Neurological Disorders in Medical Use Of Canabis: an Update. CNS Neurol Disord Drug Targets. 2017, 16(5):527-533.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Grupo de Interés Espacial en Dolor (GIED).
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
